SecBot SecBot
SECBOTREPLAY Home › Report › RLAY

RLAY · Relay Therapeutics' CEO and CFO sold a combined $1.33M in open-market…

Relay Therapeutics, Inc. · CLUSTER filed Aug 18, 2026 at 16:17 ET

At the news

BEARISHIMPACT 5/10

CLUSTER filed Aug 18, 2026 at 16:17 ET

Relay Therapeutics' CEO and CFO sold a combined $1.33M in open-market sales over a 4-day window, representing ~0.03% of the $4.5B market cap. While the dollar amount is trivial relative to company size, the cluster involves both the CEO and CFO selling simultaneously, which is notable for a biotech with a $4.5B market cap and 95% analyst bullishness. The sales are not part of a 10b5-1 plan pattern and occur without any disclosed negative catalyst, suggesting potential insider caution ahead of upcoming pipeline data or earnings.

  • CEO Sanjiv Patel sold 48,199 shares for $979,886 on 2026-08-17
  • CFO Thomas Catinazzo sold 17,717 shares for $349,734 on 2026-08-14
  • Total insider sales of $1.33M represent ~0.03% of $4.5B market cap
  • Both sales are open-market (code S), not 10b5-1 plan or tax withholding

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access